These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

596 related items for PubMed ID: 19739235

  • 1. Detection of hematogenous bone metastasis in cervical cancer: 18F-fluorodeoxyglucose-positron emission tomography versus computed tomography and magnetic resonance imaging.
    Liu FY, Yen TC, Chen MY, Lai CH, Chang TC, Chou HH, Hong JH, Chen YR, Ng KK.
    Cancer; 2009 Dec 01; 115(23):5470-80. PubMed ID: 19739235
    [Abstract] [Full Text] [Related]

  • 2. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
    Kauhanen SP, Komar G, Seppänen MP, Dean KI, Minn HR, Kajander SA, Rinta-Kiikka I, Alanen K, Borra RJ, Puolakkainen PA, Nuutila P, Ovaska JT.
    Ann Surg; 2009 Dec 01; 250(6):957-63. PubMed ID: 19687736
    [Abstract] [Full Text] [Related]

  • 3. 18F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation.
    Ng SH, Yen TC, Liao CT, Chang JT, Chan SC, Ko SF, Wang HM, Wong HF.
    J Nucl Med; 2005 Jul 01; 46(7):1136-43. PubMed ID: 16000282
    [Abstract] [Full Text] [Related]

  • 4. Prospective comparison of [18F]fluorodeoxyglucose positron emission tomography and computed tomography in patients with melanoma with palpable lymph node metastases: diagnostic accuracy and impact on treatment.
    Bastiaannet E, Wobbes T, Hoekstra OS, van der Jagt EJ, Brouwers AH, Koelemij R, de Klerk JM, Oyen WJ, Meijer S, Hoekstra HJ.
    J Clin Oncol; 2009 Oct 01; 27(28):4774-80. PubMed ID: 19720925
    [Abstract] [Full Text] [Related]

  • 5. 18F-FDG PET/CT for staging of penile cancer.
    Scher B, Seitz M, Reiser M, Hungerhuber E, Hahn K, Tiling R, Herzog P, Reiser M, Schneede P, Dresel S.
    J Nucl Med; 2005 Sep 01; 46(9):1460-5. PubMed ID: 16157528
    [Abstract] [Full Text] [Related]

  • 6. Diagnostic performance of fluorodeoxyglucose-positron emission tomography/computed tomography of breast cancer in detecting axillary lymph node metastasis: comparison with ultrasonography and contrast-enhanced CT.
    Monzawa S, Adachi S, Suzuki K, Hirokaga K, Takao S, Sakuma T, Hanioka K.
    Ann Nucl Med; 2009 Dec 01; 23(10):855-61. PubMed ID: 19876704
    [Abstract] [Full Text] [Related]

  • 7. [Correlation of FDG-PET and MRI/CT with histopathology in primary diagnosis, lymph node staging and diagnosis of recurrency of head and neck cancer].
    Pöpperl G, Lang S, Dagdelen O, Jäger L, Tiling R, Hahn K, Tatsch K.
    Rofo; 2002 Jun 01; 174(6):714-20. PubMed ID: 12063600
    [Abstract] [Full Text] [Related]

  • 8. Circulating tumor cells and [18F]fluorodeoxyglucose positron emission tomography/computed tomography for outcome prediction in metastatic breast cancer.
    De Giorgi U, Valero V, Rohren E, Dawood S, Ueno NT, Miller MC, Doyle GV, Jackson S, Andreopoulou E, Handy BC, Reuben JM, Fritsche HA, Macapinlac HA, Hortobagyi GN, Cristofanilli M.
    J Clin Oncol; 2009 Jul 10; 27(20):3303-11. PubMed ID: 19451443
    [Abstract] [Full Text] [Related]

  • 9. Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma.
    Roh JL, Yeo NK, Kim JS, Lee JH, Cho KJ, Choi SH, Nam SY, Kim SY.
    Oral Oncol; 2007 Oct 10; 43(9):887-93. PubMed ID: 17207656
    [Abstract] [Full Text] [Related]

  • 10. Fusion of metabolic function and morphology: sequential [18F]fluorodeoxyglucose positron-emission tomography/computed tomography studies yield new insights into the natural history of bone metastases in breast cancer.
    Du Y, Cullum I, Illidge TM, Ell PJ.
    J Clin Oncol; 2007 Aug 10; 25(23):3440-7. PubMed ID: 17592153
    [Abstract] [Full Text] [Related]

  • 11. Detection of occult bone metastases from head and neck squamous cell carcinoma: impact of positron emission tomography computed tomography with fluorodeoxyglucose F 18.
    Basu D, Siegel BA, McDonald DJ, Nussenbaum B.
    Arch Otolaryngol Head Neck Surg; 2007 Aug 10; 133(8):801-5. PubMed ID: 17709620
    [Abstract] [Full Text] [Related]

  • 12. Positron emission tomography/computed tomography with 18fluoro-deoxyglucose in the detection of local recurrence and distant metastases of pediatric sarcoma.
    Arush MW, Israel O, Postovsky S, Militianu D, Meller I, Zaidman I, Sapir AE, Bar-Shalom R.
    Pediatr Blood Cancer; 2007 Dec 10; 49(7):901-5. PubMed ID: 17252575
    [Abstract] [Full Text] [Related]

  • 13. A meta-analysis of ¹⁸FDG-PET-CT, ¹⁸FDG-PET, MRI and bone scintigraphy for diagnosis of bone metastases in patients with lung cancer.
    Qu X, Huang X, Yan W, Wu L, Dai K.
    Eur J Radiol; 2012 May 10; 81(5):1007-15. PubMed ID: 21354739
    [Abstract] [Full Text] [Related]

  • 14. Utility of 18F-fluorodeoxyglucose positron emission tomography in the preoperative staging of squamous cell carcinoma of the oropharynx.
    Kim MR, Roh JL, Kim JS, Lee JH, Cho KJ, Choi SH, Nam SY, Kim SY.
    Eur J Surg Oncol; 2007 Jun 10; 33(5):633-8. PubMed ID: 17391904
    [Abstract] [Full Text] [Related]

  • 15. The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP Planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET/CT.
    Even-Sapir E, Metser U, Mishani E, Lievshitz G, Lerman H, Leibovitch I.
    J Nucl Med; 2006 Feb 10; 47(2):287-97. PubMed ID: 16455635
    [Abstract] [Full Text] [Related]

  • 16. Gadoxetate disodium-enhanced magnetic resonance imaging versus contrast-enhanced 18F-fluorodeoxyglucose positron emission tomography/computed tomography for the detection of colorectal liver metastases.
    Seo HJ, Kim MJ, Lee JD, Chung WS, Kim YE.
    Invest Radiol; 2011 Sep 10; 46(9):548-55. PubMed ID: 21577131
    [Abstract] [Full Text] [Related]

  • 17. (18) F-fluorodeoxyglucose positron emission tomography/computed tomography for the detection of recurrent bone and soft tissue sarcoma.
    Al-Ibraheem A, Buck AK, Benz MR, Rudert M, Beer AJ, Mansour A, Pomykala KL, Haller B, Juenger H, Scheidhauer K, Schwaiger M, Herrmann K.
    Cancer; 2013 Mar 15; 119(6):1227-34. PubMed ID: 23233156
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of 18F-FDG PET/CT and CT/MRI with histopathologic correlation in patients undergoing central compartment neck dissection for squamous cell carcinoma of the larynx, hypopharynx, and esophagus.
    Kim JW, Roh JL, Kim JS, Lee JH, Cho KJ, Choi SH, Nam SY, Kim SY.
    Oral Oncol; 2013 May 15; 49(5):449-53. PubMed ID: 23321549
    [Abstract] [Full Text] [Related]

  • 19. Detection of occult primary tumors in patients with cervical metastases of unknown primary tumors: comparison of (18)F FDG PET/CT with contrast-enhanced CT or CT/MR imaging-prospective study.
    Lee JR, Kim JS, Roh JL, Lee JH, Baek JH, Cho KJ, Choi SH, Nam SY, Kim SY.
    Radiology; 2015 Mar 15; 274(3):764-71. PubMed ID: 25405771
    [Abstract] [Full Text] [Related]

  • 20. Preoperative detection of prostate cancer: a comparison with 11C-choline PET, 18F-fluorodeoxyglucose PET and MR imaging.
    Watanabe H, Kanematsu M, Kondo H, Kako N, Yamamoto N, Yamada T, Goshima S, Hoshi H, Bae KT.
    J Magn Reson Imaging; 2010 May 15; 31(5):1151-6. PubMed ID: 20432351
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.